R. Dinwiddie (London, United Kingdom), C. Wallis (London, United Kingdom)
Side effects of inhaled tobramycin in patients with Cystic Fibrosis
V. Lucidi, T. Salerno, S. Bella, F. Libera, M. Castro (Rome, Italy)
|  |
Effect of aerosolized antibiotics on proinflammatory cytokines
C. Terzano, S. Marietti (Roma, Italy)
| |
Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF)
T. Sologub, O. Karpov, A. Zaytsev (Saint-Petersburg, Russia)
| |
Does C. pneumoniae and P. carinii infections have a different role in patients with cystic fibrosis and lung transplantation?
C. Contini, R. Cultrera, D. Buonfrate, S. Seraceni, D. Segala, D. Pignata, P. Quattrucci, E. Angelici (Ferrara, Rome, Italy)
| |
Cough plate versus cough swab in patients with cystic fibrosis
S. Maiya, A. Baruah, M. Desai, J. Clarke, P. Weller ()
| |
Breath condensate collection in children is well tolerated and not contaminated by saliva when collected using the Jaegar ecoscreen
K. Leadbetter, L. P. Ho, S. Cunningham (Edinburgh, Oxford, United Kingdom)
| |
Breath condensate is acidified during infective exacerbations in children with cystic fibrosis
D. Cain, G. MacGregor, L. P. Ho, J. A. Innes, A. Greening, S. Cunningham (Edinburgh, Oxford, United Kingdom)
| |
Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients
R. M. Effros, J. Biller, F. Sun, B. Foss (Milwaukee, United States Of America)
| |
Inflammatory markers in cystic fibrosis patients with different values of pulmonary function tests
A. L. Pukhalsky, G. V. Shmarina, S. N. Kokarovtseva, N. I. Kapranov, N. J. Kashirskaja (Moscow, Russia)
| |
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
A. L. Pukhalsky, G. V. Shmarina, S. N. Kokarovtseva, N. I. Kapranov, L. A. Shabalova (Moscow, Russia)
| |
Longitudinal evaluation of airway inflammation in stable CF patients by bronchoalveolar lavage (BAL) and influence of rhDNAse
K. P. Paul, C. Chen, T. Schink, M. Ballmann, G. Doring, M. Griese, F. Ratjen (Berlin, Hanover, Tuebingen, Munich, , Cologne, Germany)
| |
Influence of long-term inhaled rhDNase on free and total IL-8 concentration in BAL fluid in cystic fibrosis
A. Jung, J. K. Shute, C. I. U. Chen, M. Ballmann, M. Griese, F. Ratjen, E. Rietschel, K. P. Paul (Berlin, , Munich, Germany; , United Kingdom)
| |
Difference of production interleukin-4 and interferon gamma in serum in children with cystic fibrosis
T. Bulgakova, E. Surkova, T. Ses, T. Guembitskaia, L. Jelenina (Russia)
| |
Moderate improved exercise capacity in patients with cystic fibrosis after treatment with recombinant human growth hormone
A. Schibler, R. von der Heiden, P. Birrer, P. E. Mullis (Bern, Switzerland)
| |
Maximal working capacity remains normal in patients with cystic fibrosis aged 10 to 15 yrs
G. Steen, A. Lindblad, S. Redfors, B. Strandvik (Gothenburg, Sweden)
| |
Minute ventilation in infants with cystic fibrosis
S. C. Ranganathan, A. F. Hoo, S. Lum, I. Goetz, A. Bush, J. Stocks, London Cystic Fibrosis Study Group (London, ; London, United Kingdom)
| |
Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms
E. M. Nieuwhof, E. C. van der Wiel, W. Hofhuis, J. C. de Jongste, P. J. F. M. Merkus (Rotterdam, The Netherlands)
| |
Usefulness of web transmission of overnight recording of SaO2 and daily FEV1 in the early diagnosis of pulmonary exacerbations in cystic fibrosis patients
S. Bella, V. Lucidi, A. Tomassini, T. Salerno, F. D'Orio, M. Castro (Rome, Italy)
| |
The study of acquired disorders of ciliary epithelium cells in CF patients
A. G. Tchermensky, T. E. Gembitskaya, T. S. Sologub, L. F. Kovaleva, M. E. Faustova (St.-Petersburg, Russia)
| |